One size fits all: Enhanced zero-shot text classification for patient listening on social media.

Journal: Frontiers in artificial intelligence
Published Date:

Abstract

Patient-focused drug development (PFDD) represents a transformative approach that is reshaping the pharmaceutical landscape by centering on patients throughout the drug development process. Recent advancements in Artificial Intelligence (AI), especially in Natural Language Processing (NLP), have enabled the analysis of vast social media datasets, also called Social Media Listening (SML), providing insights not only into patient perspectives but also into those of other interest groups such as caregivers. In this method study, we propose an NLP framework that-given a particular disease-is designed to extract pertinent information related to three primary research topics: identification of interest groups, understanding of challenges, and assessing treatments and support systems. Leveraging external resources like ontologies and employing various NLP techniques, particularly zero-shot text classification, the presented framework yields initial meaningful insights into these research topics with minimal annotation effort.

Authors

  • Veton Matoshi
    Independent Researcher, Graz, Austria.
  • Maria Carmela De Vuono
    Know Center Research GmbH, Graz, Austria.
  • Roberto Gaspari
    Know Center Research GmbH, Graz, Austria.
  • Mark Kröll
    Chiesi Farmaceutici S.p.A, Parma, Italy.
  • Michael Jantscher
    Chiesi Farmaceutici S.p.A, Parma, Italy.
  • Sara Lucia Nicolardi
    Know Center Research GmbH, Graz, Austria.
  • Giuseppe Mazzola
    Know Center Research GmbH, Graz, Austria.
  • Manuela Rauch
    Chiesi Farmaceutici S.p.A, Parma, Italy.
  • Vedran Sabol
    Chiesi Farmaceutici S.p.A, Parma, Italy.
  • Eileen Salhofer
    Chiesi Farmaceutici S.p.A, Parma, Italy.
  • Riccardo Mariani
    Know Center Research GmbH, Graz, Austria.

Keywords

No keywords available for this article.